Transfusion

Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.

Transfusion

Chami B, Okuda M, Moayeri M, Pirenne F, Hidaka Y, Nambiar A, Song Z, Bedel O, Zhang B, Hopke J, Deng G, Zhu C, Mac? S, Chiron M, Adrian F, Fukao T, Basile FG, Martin T

Survey of intrauterine red blood cell (RBC) transfusion practices in the United States.

Transfusion

Bakhtary S, Panchalee T, Crowe EP, Schwab ME, Zakieh A, Josephson CD, Sobhani NC, Gonzalez-Velez JM, Goel R

National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies.

Transfusion

Holmberg JA, Henry SM, Burnouf T, Devine D, Marschner S, Boothby TC, Burger SR, Chou ST, Custer B, Blumberg N, Siegel DL, Spitalnik SL

Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.

Transfusion

Stramer SL, Lanteri MC, Brodsky JP, Foster GA, Krysztof DE, Groves JA, Townsend RL, Notari E, Bakkour S, Stone M, Simmons G, Spencer B, Tonnetti L, Busch MP

Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee.

Transfusion

Metcalf RA, Cohn CS, Allen ES, Bakhtary S, Gniadek T, Gupta G, Harm S, Haspel R, Hess A, Jacobson J, Lokhandwala PM, Murphy C, Poston J, Prochaska MT, Raval JS, Saifee NH, Salazar E, Shan H, Zantek N, Pagano MB

How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?

Transfusion

Fink RV, Fisher L, Sulaeman H, Dave H, Levy ME, McCann L, Di Germanio C, Notari EP, Green V, Cyrus S, Williamson P, Saa P, Haynes JM, Groves J, Mathew S, Kaidarova Z, Bruhn R, Grebe E, Opsomer J, Jones JM, Miller MJ, Busch MP, Stone M

Cost-effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogens.

Transfusion

Grégoire Y, Delage G, Custer B, Rochette S, Renaud C, Lewin A, Germain M

The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Transfusion

Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, Busch MP, Chapman K, Dinardo C, Hendrickson J, Hod EA, Kelly S, Luban N, Mast A, Norris P, Custer B, Sabino E, Sachais B, Spencer BR, Stone M, Kleinman S, National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-

Reprogramming of red blood cell metabolism in Zika virus-infected donors.

Transfusion

Catala A, Stone M, Busch MP, D'Alessandro A

Pages